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 SUMMARY 
Antimicrobial resistance (AMR) is a fast growing global threat in several perspectives. In 
medicine the antimicrobials are crucial in the treatment of some diseases and without the 
antimicrobials those diseases might be fatal. In veterinary medicine antimicrobials are used as 
treatment, prevention and growth promoters and without them it would be difficult to handle 
some diseases which could result in extensive economic losses for the animal owner as well as 
for the society as a whole, especially in developing countries.  
Excessive and imprudent use of antibiotics may contribute to the development and 
dissemination of resistant bacteria and genes. Several studies have shown a risk for 
dissemination of resistant bacteria from food animals to humans and therefore measures have 
been taken on national as well as on international levels to curb this progression. One example 
of such measures is surveillance systems to monitor the resistance pattern of selected microbes 
regularly. A gained knowledge about the resistance patterns, along with knowledge about 
resistance mechanisms, makes it possible to adjust regulations and recommendations for 
antibiotic usage so that less broad-spectrum antibiotics are used in favor for the narrow-
spectrum antibiotics or, for that matter, no antibiotics at all. 
Improvements in preventive management such as good hygiene and biosecurity would also 
decrease the need for antimicrobials in animals and livestock which would be beneficial in 
hindering the progression of AMR.  
This study aims to contribute to the important monitoring and mapping of AMR in livestock. 
The pig production in Thailand is expanding and an increasing number of large-scaled farms 
are appearing at the same time as the number of smaller farms decreases. Therefore Thailand 
was chosen for this study. 
In this study indicator Escherichia coli was cultured from rectal swabs from healthy sows on 
27 medium-sized (100-500 sows) farms in the northeast of Thailand. Samples were collected 
from three sows at each farm, resulting in 81 samples in total. To test them for antibiotic 
susceptibility a VetMIC GN-mo panel was used – a MIC-based (minimum inhibitory 
concentration) broth-microdilution method. Antibiotic substances included in the study were: 
amoxicillin, ciprofloxacin, nalidixic acid, gentamicin, streptomycin, tetracycline, florfenicol, 
colistin, sulfamethoxazole, trimethoprim, chloramphenicol, meropenem, cefotaxime and 
ceftazidime.  
At each farm a questionnaire was also filled in to enable identification of possible risk factors 
for antibiotic resistance. The questions were chosen and formulated in a manner that would give 
us insight in the routines regarding antibiotic usage, husbandry and health status of the pigs. 
From 81 samples, 81 Escherichia coli isolates were obtained. The percentage of resistant 
isolates among the tested isolates for each of the included antibiotics was as follows: ampicillin 
(85.2%), ciprofloxacin (48.1%), nalidixic acid (30.8%), gentamicin (7.4%), streptomycin 
(76.5%), tetracycline (86.3%), florfenicol (2.4%), colistin (0.0%), sulfamethoxazole (84.0%), 
trimethoprim (70.4%), chloramphenicol (58.0%), cefotaxime (1.2%) and ceftazidime (3.7%). 
Multidrug resistance (MDR) was found in 95.1% of the isolates. The variations in management 
 and antibiotic usage among the farms were very small and therefore statistical relationships 
could not be obtained in regards to management, antibiotic usage and antibiotic resistance.  
Some of the results for meropenem were found to be unreliable. One of the strains (M13) had 
nevertheless a high minimum inhibitory concentration (MIC) for meropenem as well as for 
other betalactams and is therefore possibly ESBLCARBA-producing (extended spectrum 
betalactamase- and carbapenemase-producing). Such finding would be perturbing since an 
ESBLCARBA-producing strain are resistant to several highly important antimicrobials. This 
result needs however to be further investigated with PCR (polymerase chain reaction).  
Although there are undertakings regarding AMR in Thailand, the usage of antimicrobials in 
animals remains less defined and the presence of AMR seems to be high compared to Sweden 
and Europe as well as Canada. An AMR surveillance program is necessary in Thailand as well 
as other Southeast Asian countries to be able to draw plausible conclusions regarding the AMR 
and the effect of antibiotic usage in this region.  
This study shows a wide use of antibiotics in the farms included. All of the farms administered 
antibiotics to the sows as injection as a routine after farrowing. The results from the antibiotic 
susceptibility tests display a generally high resistance frequency for a majority of the included 
antibiotics. This indicates that a wide use of antibiotics results in resistant bacteria, which makes 
a prudent antibiotic use, as well as surveillance systems, crucial to curb the development of 
more resistant bacteria. 
SAMMANFATTNING 
Antimikrobiell resistens (AMR) är ett globalt växande problem ur såväl humanmedicinska, 
veterinärmedicinska och samhällsekonomiska perspektiv.  Antimikrobiella läkemedel är 
avgörande för behandlingen av vissa sjukdomar och utan rätt behandling kan dessa sjukdomar 
innebära dödlig utgång. Inom veterinärmedicin används antimikrobiella medel i behandlingen 
av sjukdomar såväl som i förebyggande och tillväxtfrämjande syfte.   Brist på fungerande 
antimikrobiella medel kan därför resultera i omfattande ekonomiska förluster för djurägare 
såväl som för hela samhället, speciellt i utvecklingsländer. 
Den utbredda och ansvarslösa användningen av antibiotika bidrar till utvecklingen och 
spridningen av resistenta bakterier och resistensgener. Flera studier har påvisat en risk för 
spridning av resistenta bakterier från produktionsdjur till människa, därför har åtgärder vidtagits 
på nationell- och internationell nivå för att motverka denna utveckling. Exempel på åtgärder är 
de övervakningssystem som finns i många länder för att regelbundet se över resistensmönster 
av utvalda mikrober. Med ökad kunskap om resistens samt om mekanismerna bakom 
resistensutvecklingen är det möjligt att förändra regler och rekommendationer för 
antibiotikaanvändning så att antibiotika med brett spektra ersätts av de med smalare spektra, 
alternativt att antibiotika inte används alls i de fall det inte behövs. 
Förbättringar i förebyggande åtgärder så som god hygien och ökad biosäkerhet skulle minska 
behovet av antimikrobiella medel till produktionsdjur, vilket också skulle bidra till förbättring 
av resistensläget. 
 Denna studie ämnar bidra till den så viktiga övervakningen och kartläggningen av AMR hos 
livsmedelsproducerande djur. Grisproduktionen i Thailand är omfattande och mängden gårdar 
med storskalig grisproduktion ökar kontinuerligt, därför var Thailand ett lämpligt val för 
studien. 
I denna studie isolerades indikatorbakterier av arten Escherichia coli från rektalsvabbar från 
friska suggor på 27 medelstora (100-500 suggor) grisgårdar i nordöstra Thailand. Prover togs 
från tre suggor på varje gård vilket resulterade i totalt 81 prover. Känslighetstestet utfördes med 
hjälp av VetMIC (panel GN-mo), vilket är en MIC-baserad (minimum inhibitory 
concentration=minsta hämmande koncentration) buljong-mikrodilutionsmetod. Följande 14 
antibiotikasubstanser testades i studien: amoxicillin, ciprofloxacin, nalidixinsyra, gentamicin, 
streptomycin, tetracyklin, florfenikol, kolistin, sulfametoxazol, trimetoprim, kloramfenikol, 
meropenem, cefotaxim och ceftazidim. 
På varje gård besvarades ett frågeformulär för att identifiera möjliga riskfaktorer för 
antimikrobiell resistens. Frågorna var utvalda och formulerade på ett sätt som kunde ge insyn i 
rutinerna i antibiotikaanvändning, skötsel och hälsostatus hos grisarna. 
Eschericha coli kunde isoleras från alla 81 prover. Andelen resistens för respektive 
antibiotikum var följande: ampicillin (85,2 %), ciprofloxacin (48,1 %), nalidixinsyra (30,8 %), 
gentamicin (7,4 %), streptomycin (76,5 %), tetracyklin (86,3 %), florfenikol (2,4 %), kolistin 
(0,0 %), sulfametoxazol (84,0 %), trimetoprim (70,4 %), kloramfenikol (58,0 %), cefotaxim 
(1,2 %) och ceftazidim (3,7 %). Multiresistens (MDR) observerades hos 95,1 % av alla isolat. 
Variationerna i skötsel, hälsostatus och antibiotikaanvändning mellan gårdarna var mycket små 
och därför kunde inte statistiska samband observeras mellan dessa faktorer och 
antibiotikaresistensen. 
En del av resultaten för meropenem konstaterades vara opålitliga och togs därför bort ifrån 
studien. En av stammarna (M13) hade dock ett högt MIC-värde för både meropenem och de 
andra betalaktamerna vilket innebär att den skulle kunna vara ESBLCARBA-producerande. Ett 
sådant fynd är oroande eftersom en ESBLCARBA-producerande stam är resistent mot flera av 
våra viktigaste antibiotika. Detta resultat behöver emellertid undersökas vidare med polymerase 
chain reaction (PCR).  
Trots vidtagna åtgärder gällande antimikrobiell resistens i Thailand råder oklarheter i 
användandet av antimikrobiella medel till djur. Man ser också att förekomsten av resistenta 
bakteriestammar förefaller vara vanligare än i såväl Sverige och Europa som Kanada. Ett 
övervakningsprogram är nödvändigt i Thailand och andra Sydostasiatiska länder för att kunna 
dra några slutsatser rörande den antimikrobiella resistensen och effekten av 
antibiotikaanvändningen i denna region. 
Denna studie visar en utbredd antibiotikaanvändning på de inkluderade gårdarna. Alla gårdar 
hade som rutin att ge en antibiotikainjektion efter grisning. Resultaten från resistenstesten 
visade en generellt hög resistensförekomst mot majoriteten av inkluderade antibiotika. Detta 
indikerar att en utbredd antibiotikaanvändning kan resultera i resistenta bakterier. En 
ansvarsfull användning, såväl som övervakningssystem, är således nödvändigt för att bromsa 
utvecklingen av fler resistenta bakterier. 
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ABBREVIATIONS 
AD – Aujeszky’s disease 
AMR – Antimicrobial resistance 
AR – Atrophic rhinitis 
CAMHB – Cation-adjusted Mueller Hinton Broth 
CSF – Classical swine fever 
E. coli – Escherichia coli 
EUCAST – European Committee on Antimicrobial Susceptibility Testing 
FAO – Food and Agriculture Organization of the United Nations 
FMD – Foot-and-mouth disease  
GPA – Growth Promoting Antibiotics 
MDR – Multidrug Resistance 
MIC – Minimum Inhibitory Concentration  
OIE – World Organization for Animal Health 
PCR – Polymerase Chain Reaction 
PCU – Population Correction Unit 
SVA – The National Veterinary Institute of Sweden 
WHO – World Health Organization 
Abbreviations for antibiotic substances 
AMP – Ampicillin  
AXC – Amoxicillin-clavulanic acid 
AZI – Azithromycin  
CAZ – Ceftazidime  
CHL – Chloramphenicol  
CIP – Ciprofloxacin 
COL – Colistin  
COT – Cefotaxime 
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COX – Cefoxitin  
CTI – Ceftiofur  
CTR – Ceftriaxone  
FLO – Florfenicol  
GEN – Gentamicin  
KAN – Kanamycin  
NAL – Nalidixic acid  
SSZ – Sulfisoxazole  
STR – Streptomycin  
SUA – Sulfonamides  
SUM – Sulfamethoxazole  
TET – Tetracycline  
TRIM – Trimethoprim    
TRSU – Trimethoprim-sulfamethoxazole 
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INTRODUCTION 
Antimicrobial resistance 
Antimicrobial resistance (AMR) is a trait among microorganisms which refer to their ability to 
survive antimicrobial agents that they originally were sensitive to. In bacteria these features are 
gained naturally through chromosomal mutations or gene transfer from one bacterium to 
another (Furuya & Lowy, 2006). AMR has raised concerns for decades since patients infected 
with resistant bacterial strains may not respond well to treatment resulting in impaired recovery 
or death (EFSA, 2011).  
The World Health Organization (WHO) reported in 2013 that antibiotic-resistant infections cost 
an estimated 1,500 million EUR in the European Union and 2,000 million USD in Thailand 
each year (WHO, 2013). In the same report WHO states that nosocomial infections with 
multidrug resistant bacteria cause 30,000 deaths every year in Thailand, more than 25,000 in 
EU, more than 23,000 in USA and approximately 80,000 in China. 
A renowned reason to the development and dissemination of AMR is the widespread use of 
antimicrobials in livestock (FAO & WHO, 2015). A publication involving seven European 
countries was issued quite recently showing a high degree of correlation between antibiotic 
usage and antibiotic resistance in food producing animals (Chantziaras et al., 2014). Van 
Boeckel et al. (2015) were the first to assess the average global consumption of antimicrobials 
in food animals per year by statistical calculations and estimated that 63,151 ± 1,560 tons were 
used in 2010. In the same report they predicted that this consumption will increase with 67% 
between 2010 and 2030.  
Particular concerns have been raised regarding the use in healthy animals to enhance their 
growth, productivity and reproduction. In 1969 the Swann Committee became the first to report 
concerns about the subtherapeutic antibiotic use in livestock and the sequent risks of selecting 
resistant bacterial strains that possibly could infect humans and result in treatment failure in 
human medicine (Swann, 1969: see Adjiri-Awere & Van Lunen, 2005). Several antibiotics are 
used for this purpose on a daily basis in subtherapeutic doses in the animal feed. Due to the risk 
to increase the AMR growth promoting antibiotics (GPAs) are not allowed in the EU since 
20061 although some countries banned GPA long before this legislation and Sweden was the 
first to proscribe GPA in 1986 (Cogliani et al., 2011). 
Antibiotics are also given as prophylaxis in low dose to healthy livestock to prevent disease 
especially in high population densities. However, this doesn’t differ from GPA from a microbial 
perspective (You & Silbergeld, 2014). 
On the World Veterinary Day 2012, the Food and Agriculture Organization of the United 
Nations (FAO) stated that it is now well-established that the imprudent use of antimicrobials 
may result in AMR (FAO, 2015). Several studies indicate that appearing resistant bacteria in 
humans may have a food-animal origin and thereby support the theory of dissemination of AMR 
bacteria from food animals to humans (Ramchandani et al., 2005; Smith et al., 2009; Bezanson 
                                                 
1 Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives 
for use in animal nutrition 
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et al., 1983). FAO has formed a tripartite together with WHO and OIE with a “One Health” 
approach which aims to coordinate the public health sectors, animal health sectors and the food 
safety in a global manner. The Tripartite consider the AMR a priority topic for concerted actions 
and has since 2003 provided information about AMR as well as developed recommendations 
and guidelines to prudent use of antimicrobials (WHO, 2014).   
Nevertheless, there have been debates on whether or not the antibiotic use in animals poses an 
actual threat to human health. Phillips et al. (2004) question this statement and conclude that 
even though resistance may spread the possibility of harm in human is low. However, they also 
emphasize the importance of food hygiene, prudent antibiotic use as well as surveillance of 
diseases and AMR.  
Objectives of field work 
This is primarily a descriptive study which aims to fill in some of the empty spaces regarding 
the antibiotic resistance among livestock in Thailand. The antibiotic usage in Thailand and 
Sweden differs markedly, which is why we also investigated whether the resistance pattern 
differs accordingly. Additionally the results were compared with data on indicator E. coli from 
Europe and Canada. Those areas were chosen because of their size and location (relatively large 
areas on two different continents) and also because of their well collected and accessible 
surveillance data.  
Furthermore, the author wanted to identify possible correlations between antibiotic resistance 
and farm management including antibiotic usage, therefore a questionnaire was included in the 
study. 
Parallel with this study, another study was performed in the same area, which had the same 
objectives as this study although with backyard small-scale-farms instead of medium-sized 
farms (Karlsson forthcoming). In backyard farming there are not always fattening pigs and 
therefore, to reach comparable results with that study, samples were collected from sows instead 
of fattening pigs although sampling from fattening pigs are recommended in the Decision 
2013/652/EU2. 
Considering the available resources, the following sampling strategy was chosen: rectal swabs 
collected from three healthy sows on each of the 27 farms, 81 samples in total. This aimed to 
achieve as comparable results as possible with those received in the surveillance programs of 
EU and Canada as well as in the study regarding the backyard-farming.  
Escherichia coli has three characteristics which make it particularly suitable as indicator 
bacteria: (i) it is commensal and does not commonly affect human nor animal health, (ii) it is 
easy to culture and (iii) it has the ability to transfer genes encoding antibiotic features to other 
bacteria and thereby is still relevant in the antimicrobial resistance problem. 
The method used in this study is the same as the broth microdilution method issued by the 
European Committee on Antimicrobial Susceptibility testing (EUCAST) (2003). The method 
                                                 
2 Commision implementing decision of 12 November 2013 on the monitoring and reporting of antimicrobial 
resistance in zoonotic and commensal bacteria [2013] OJ L303/26 
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is also in accordance with the European Standard (EN ISO 20776-1:2006) (European 
Committee for standardization, 2006) which thereby enables the results to be compared with 
European countries including Sweden. 
Multidrug resistance 
In 2011 an international expert group jointly decided a terminology to be used for multidrug 
resistance (MDR) or multiresistance and agreed on defining it as acquired non-susceptibility to 
at least one agent in three or more antimicrobial categories (Magiorakos et al., 2011). This is 
also the classification used by The National Veterinary Institute (SVA, 2014).  
The antimicrobial categories used in this study were as follows: 
Category Antibiotic substance 
Aminoglycosides Gentamicin, streptomycin 
Amphenicols Chloramphenicol, florfenicol 
Carbapenems Meropenem 
Cephalosporins Cefotaxime, ceftazidime 
Folate pathway inhibitors Trimethoprim, sulfamethoxazole 
Penicillins Ampicillin 
Polymyxins Colistin 
Quinolones Ciprofloxacin, nalidixic acid 
Tetracyclines Tetracycline 
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LITERATURE STUDY 
Pig industry in Thailand 
Industrialization of pig farming started in 1973 and the development of large-scale farms 
accelerated in the 1980s (Cameron, 2000). Nowadays pig production in Thailand is widespread. 
It should be noted that the estimated numbers from this industry are somewhat scattered 
depending on source and reporting frequency etc. Therefore one might question the accuracy 
of them. The collected information is presented below without further assumptions or 
conclusions.  
According to Cameron (2000) 80% of pigs produced in Thailand were from intensive farming 
systems at the time for its publication. More than half of these were from farms with >1000 
pigs (8.5% from company owned farms and 47.5% from privately owned farms). The remaining 
44% of pigs from intensive farming systems were from farms with 50-1000 pigs.  
Thailand produced more than 16 million fattening pigs in 2013 and the export value of pigs, 
pork and products was worth 4.5 billion THB (Tantasuparuk & Kunavongkrit, 2014). 
According to FAO the export value of live animals (pigs) was in 2013 approx. 32 million USD 
(FAOSTAT, 2016), equivalent to ~26 % of the total export value from the Thai pig and pork 
industry. 
Data from the Thai Department of Livestock 
Development (DLD) shows a number of 9.5 
million pigs in 191,454 households in 2014 
(National Institute of Animal Health, 2014). 
According to Tantasuparuk & Kunavongkrit 
(2014) 94% of the farms held less than 50 pigs 
each in 2013, while 0.1% held more than 5000 
pigs. The same authors stipulated that the 
number of large-scaled productions had 
increased and might continue to do so.  
Reproductive performance and diseases 
in Thailand 
Thailand import sows from the same sources 
as Europe yet the reproductive performance 
are not as high in Thailand as in Europe and 
the litter sizes are smaller (Tantasuparuk & 
Kunavongkrit, 2014) which could be a result 
of the hot and humid weather (Suriyasomboon 
et al., 2006). The climate is suitable for 
bacterial and fungal growth which may affect 
the reproduction of sows and the quality of 
feed (Tantasuparuk & Kunavongkrit, 2014). 
Reproductive performance in sows in Thailand 
Table 1.  Reported disease occurrences in 
small animals in Thailand. The numbers are 
collected from the Annual report of National 
Institute of Animal Health (2014). Pigs 
represented 95.0% of the included animals in 
the report. 
Disease Number of  
diagnosed cases 
Rabies 182 
PRRS 40 
Classical swine fever 17 
Porcine circovirus 32 
PMWS (Circovirus 
infection) 
1 
Porcine parvovirus 1 
Colibacillosis 12 
Edema disease 15 
Streptococcosis 5 
Clostridial infection 1 
Pasteurellosis 3 
Salmonellosis 1 
Bacterial infection 2 
Glasser's disease 4 
Swine dysentery 1 
Total 317 
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is lowered due to several diseases including classical swine fever, foot and mouth disease, 
PMWS (porcine circovirus), porcine epidemic diarrhea and PRRS (porcine reproductive and 
respiratory syndrome).  
Reported disease occurrences in “small animals” (of which pigs represent 95%) are displayed 
in a publication issued by the National Institute of Animal Health (2014) and shown in Table 
1. Note that this is diagnosed and reported cases, not a complete picture of disease incidence in 
Thailand.  
Surveillance of antibiotic usage in animals and livestock and antimicrobial 
resistance in Thailand  
The Thai Department of Livestock Development (DLD) cooperates with the Thai Food and 
Drug Administration (TFDA), Ministry of Public Health in the regulation of veterinary drugs 
(FAO, 2014a). DLD is responsible for the control and surveillance of the usage of veterinary 
drugs, furthermore they list drugs and chemicals that are not permitted for use in food animals. 
The TFDA has responsibility for licensing and registration of veterinary medicinal products 
and authorizes officials of DLD.  
No national surveillance and data collection system exists for antimicrobial resistance in 
livestock and livestock products, although there have been some studies on AMR performed in 
Thailand, according to the review published by FAO (2014a). Suggested challenges include the 
lack of standardized and harmonized methods for antimicrobial susceptibility testing, the 
insufficient regulations and unclear picture of antimicrobial usage in farm animals as well as 
personnel with inadequate competence.  
Nevertheless, there are ongoing undertakings in this area. The government of Thailand has 
included surveillance of AMR in human and animals in the National Strategic Plan for 
Emerging Infectious Disease (Bureau of Emerging Infectious Disease, Department of Disease 
Control. Ministry of Public Health, 2013), the DLD is currently working on a project to 
harmonize the monitoring of AMR in Thailand and the National Institute of Animal Health 
(NIAH), established by DLD, is responsible for the surveillance of antibiotic susceptibility 
(National Institute of Animal Health, 2016). Guidelines of judicious antimicrobial use in 
poultry have had a positive response among Thai producers and there are ongoing preparations 
of guidelines customized for other livestock animals. Furthermore, the TFDA has banned the 
usage of antibiotics for growth promotion purposes in food animals. 
The National Antimicrobial Resistance Surveillance Center, Thailand (NARST) receives data 
on antimicrobial resistance from several hospitals in the country. With support from the WHO 
the program was initiated in 1998 to investigate the antimicrobial susceptibility of various 
microorganisms (Dejsirilert et al., 2009). Moreover, Thailand has joined the global antibiotic 
resistance surveillance program SMART (Study for Monitoring Antimicrobial Resistance 
Trends) that started in 2002 and was initiated to monitor antimicrobial resistance and 
epidemiological trends among patients with intraabdominal infections (Hsueh, 2012). 
However, these programs monitor only human hospitals and thereby only include unhealthy 
individuals that likely are under treatment.  
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According to FAO (2014a) the resistance pattern in commensal E. coli from livestock is well 
studied in South, East and Southeast Asia and the results have shown a high resistance in E. 
coli to amoxicillin, ampicillin and tetracycline in all of the studies reviewed. However, only 
two studies on AMR in E. coli from pigs in Thailand were included in that review and the names 
of those studies were not specified which hinder further inquiry.  
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Antibiotic usage and surveillance in pigs in Sweden 
In 2015 data about the Swedish antibiotic consumption for pigs showed that 2883 kg active 
antibiotic substance was used in 2014 and 75% (approx. 2160 kg) of these were injectable 
products (SVA, 2015). Benzylpenicillin was the most commonly used antibiotic substance, 
60% of all the injectable antibiotic products sold contained benzylpenicillin. Fluoroquinolones 
are not commonly used in pigs in Sweden (3.2 kg active substance in 2014) and no usage of 
third generation cephalosporins in pigs are reported. Over time, the selling of antibiotic products 
for group medication has decreased. However, the sales of benzylpenicillin for injection has 
instead increased and so has the total amount of injectable antibiotics, therefore the total 
antibiotic consumption in pigs has been rather constant over the last years.  
Antibiotic administration via feed or water contributes to selection of resistant bacteria in a 
higher degree compared with individual treatment with narrow-spectrum injectable antibiotics, 
e.g. benzylpenicillin (SVA, 2015). Thus the change from group medication to individual 
treatments is beneficial even though the total amount of antibiotics has not changed.  
The latest publication from the surveillance of AMR in indicator E. coli from pigs in Sweden 
was issued in 2012 (SVA, 2012). The results from that publication are presented in Table 2 and 
3 and further explained under Discussion. 
Antimicrobial usage in Sweden is low compared to other countries in the EU. In the fifth 
ESVAC report regarding sales of veterinary antimicrobial agents (EMA & ESVAC, 2015) 
Sweden is reported to have the third lowest usage of veterinary antimicrobials among 26 
European countries – 12.6 mg/population correction unit (PCU) compared to an average of 
109.7 mg/PCU. Population correction unit (PCU) is purely a technical term, used by EMA & 
ESVAC, to take into account the animal demographics in individual countries. One PCU 
corresponds to one kg animal weight. 
Antibiotic susceptibility in Canada, Europe, Sweden and Thailand 
Antibiotic usage differs markedly between Thailand and Sweden, which makes it interesting to 
investigate whether the resistance pattern differs accordingly. Europe and Canada were chosen 
for comparison because of their size and location (relatively large areas on two different 
continents) and also because of their well collected and accessible surveillance data. 
The resistance pattern for the different areas is shown in Table 2 and 3. 
Canada 
In the Canadian Integrated Program for Antimicrobial Resistance Surveillance Annual Report 
2013 (CIPARS, 2015), 1573 isolates of E. coli from pig feces were tested for antimicrobial 
susceptibility. Composite fecal samples were collected from 6 pens with grower-finisher pigs 
once per year. The antibiotic susceptibility methods were essentially the same as used in this 
study. Although it needs to be taken into account that the breakpoints applied in that report, 
were in general a little higher than the ECOFFs presented in this study (especially ciprofloxacin 
where the breakpoint is considerably higher than the ECOFF), therefore some of the strains that 
were classified as resistant in this study would not be considered resistant in the Canadian 
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report. As a result the Canadian numbers in Table 2 and 3 might be lower than it would be with 
ECOFFs. 
Europe 
The European report (EFSA & ECDC, 2015) included 1954 isolates of E. coli from 10 member 
states in reporting AMR. Isolates originated from either fattening pigs (seven countries) or 
breeding animals (one country) or un-specified production type (two countries). The majority 
of samples were collected randomly from healthy slaughter pig carcasses at the slaughterhouse. 
Sample collection was relatively evenly distributed over the year. Belgium, Hungary and 
Poland did not report detailed information on sampling stage, sample type or sampling context. 
In the analysis of MDR, 1312 isolates from seven countries were included. As in this study, 
ECOFFs were used for interpretation. In 2013 broth microdilution methods were established as 
the harmonized method for testing antibiotic susceptibility in EU, although it is not specified 
whether this method was used or not by the included countries in the report. 
Sweden 
In the Swedish report (SVA, 2012) 167 isolates of E. coli was included. The samples were 
collected from intestinal content of healthy pigs at slaughter. Each isolate was from a unique 
herd. Isolation, identification and susceptibility testing were the same as in this study. 
Thailand 
A Thai study (Jiwakanon et al., 2008) collected 338 isolates between 2003 and 2005 from fecal 
samples from pig farms in northeastern Thailand. Samples were collected by veterinary service 
officers and were sent to Veterinary Research and Development center, Upper Northeastern 
region. Collection method was not mentioned neither were the number of samples per farm. 
Antimicrobial susceptibility was tested with a disk diffusion method according to the National 
Committee for Clinical Laboratory Standards (NCCLS), now called Clinical Laboratory 
Standard Institute (CLSI). The breakpoints used for interpretation were also according to 
NCCLS.  
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Table 2. Antimicrobial susceptibility in pigs in Canada, Europe, Sweden and Thailand. GEN=Gentamicin, KAN=Kanamycin, STR=Streptomycin, 
AMP=Ampicillin, CTR=Cefteriaxone, COX=Cefoxitin, CTI=Ceftiofur, COT=Cefotaxime, CAZ=Ceftazidime, SSZ= Sulfisoxazole, TRSU= Trimethoprim-
sulfamethoxazole, SUM=Sulfamethoxazole, SUA=Sulfonamides, CHL=Chloramphenicol, FLO=Florfenicol, COL=Colistin, CIP=Ciprofloxacin, NAL=Nalidixic 
acid, TET=Tetracycline. Dash mark (-) means non-tested. Numbers are collected from CIPARS, 2015; EFSA & ECDC, 2015; SVA, 2012; Jiwakanon et al., 2008 
and this report (Thailand, 2015). 
Area  
(Number of  
isolates tested) Percent of isolate resistant by antimicrobial category 
  
Amino- 
Glycosides Penicillins Cephalosporines Folate pathway inhibitors Amphenicols Polymyxines Quinolones Tetracyclines 
  GEN KAN STR AMP CTR COX CTI COT CAZ SSZ TRSU TRIM SUM SUA CHL FLO COL CIP NAL TET 
Canada  
(1573) 1.0 12.5 34.0 31.1 1.3 1.1 1.1 - - 45.4 13.4 - - - 20.3 - - - 0.3 75.4 
Europe  
(1954) 1.8  47.8 30.3 - - - 1.3 - - - - - 42.1 14.7 - - 6.1 3.8 52.8 
Sweden  
(167) 1 1 16 13 - - - <1 - - - 11 - 17 4 0 0 2 2 8 
Thailand, 2008 
(338) 30.8 40.8 66.3 84.5 - - - 0.5 - - 85.2 - - - - - 3.5 26.8 37.6 97.9 
Thailand, 2015 
(81) 7.4  76.5 85.2 - - - 1.2 3.7 - - 70.4 84.0 - 58.0 2.4 0 48.1 30.8 86.3 
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Table 3. Resistance by number of antimicrobials in pigs in Canada, Europe, Sweden and Thailand. In the Canadian report the resistance against 2 and 3 
antibiotics were merged and not divided as in the other reports. Therefore “44.7%” refers to resistance against 2 or 3 antibiotics.  Dash (-) means non-
evaluated. Numbers are collected from CIPARS, 2015; EFSA & ECDC, 2015; SVA, 2012; Jiwakanon et al., 2008 and this report (Thailand, 2015) 
Area 
(Numbers of 
isolates tested) 
Percentage isolates by number of antimicrobial 
categories in the resistance pattern 
  0 1 2 3 >3 
Canada  
(1573) 
16.5 20.5 44.7 18.3 
Europe 
(1312) 
- - - - 39.9 
Sweden  
(167) 
72 9 5 3 10 
Thailand, 2008 
(338) 
- - - - - 
Thailand, 2015 
(81) 
2.5 0 2.5 8.6 87.7 
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Studies on ESBL and ESBLCARBA 
Extended-spectrum beta lactamases (ESBL) are enzymes that have the ability to hydrolyze 
betalactam antibiotics including 3rd and 4th generation cephalosporins as well as aztreonam (SVA, 
2015-12-08; Rawat & Nair, 2010). The betalactam antibiotics are highly important for human and 
veterinary medicine and therefore information about resistance against these antibiotics is crucial 
(WHO, 2011; EFSA, 2011). In case of infection with ESBL-producing bacteria, carbapenems are 
commonly the treatment of choice. Unfortunately the emergence of strains with acquired 
resistance against carbapenems has also recently increased, not only in human medicine but such 
strains have also been detected in animals (Fischer et al., 2012; Guerra et al., 2014). 
Carbapenemases are enzymes produced by the bacteria and are able to hydrolyze carbapenems. 
Strains that produce carbapenemase are named ESBLCARBA-producing.   
In 2014 a study on prevalence of antimicrobial resistance in pigs in Thailand was carried out 
(Boonyasiri et al., 2014). Rectal swabs were collected from randomly chosen healthy pigs (n=314) 
in northern and eastern Thailand, one swab per pig. ESBL production was detected by the double 
disk diffusion method and antibiotic susceptibility was determined with a disk diffusion method. 
Resistance against cephalosporins was detected by using selective medium agar containing 
cephalosporins. Important to note is that the high number of isolates tested with such method is 
likely to entail a higher frequency of resistance against cephalosporins than the method used in 
this study. Therefore, the respective results are not comparable. Nevertheless, 76.7% of the 
obtained isolates were found to be ESBL-producing. Two strains were resistant against 
carbapenem but it is not specified however these strains also were ESBL-producing. The 
carbapenem resistance was also not confirmed with PCR and therefore it is not possible to tell 
whether the resistance was caused by a carbapenemase or not.  
Fischer et al. (2012) and Roschanski et al. (in press) report findings of carbapenem resistant strains 
in pigs from other countries. Lay et al., (2012) and Jiwakanon et al. (2008) have studied 
antimicrobial resistance in pigs in Thailand but resistance against carbapenems was not included 
in those reports. 
MATERIAL AND METHODS 
Field sampling 
A total of 27 medium-sized farms (100-500 sows) were visited for sample collection between 17th 
September and 1st October in 2015. Only one farm was private owned whereas the remaining 
twenty-six were contract farms (i.e. farms owned by companies). The companies are called A and 
B and owned fourteen and twelve of the contract farms, respectively. From each farm rectal swabs 
were collected from three healthy sows by veterinary assistants who were thoroughly instructed 
beforehand how to collect the samples in a correct manner. The samples were then transported to 
the Khon Kaen University in tubes containing Aimes medium, for analysis. Duration of transport 
was 1-6 hours. The samples were stored in 2-8°C in maximum 48 hours before analyses. 
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Isolates 
Commensal Escherichia coli were used as indicator bacteria. Each fecal sample was streaked on 
MacConkey agar and incubated at 44°C overnight. At least four colonies with typical 
morphological appearance consistent with E.coli were thereafter sub-cultured on blood agar and 
incubated at 37°C overnight. To confirm growth of E.coli, the isolates were tested for production 
of tryptophanase through incubation in Motility-Indole-Lysine (MIL) broth at 37°C overnight, 
followed by addition of Kovac’s indole reagent. One confirmed E. coli isolate from each sample 
were further tested for antimicrobial susceptibility. 
Antimicrobial susceptibility testing 
The medium used was cation-adjusted Mueller-Hinton broth (CAMHB) (Difco) with pH 7.2-7.4. 
As control stain, E. coli CCUG 17620 (ATCC 25922) was included. Bacteria were collected by 
touching 3-5 colonies on the blood agar with a plastic loop (1 µl) and suspended in 5 ml CAMHB 
followed by incubation for 1h and 50min at 37°C to reach a concentration of at least 108 CFU/ml. 
From the preculture 10 µl was transferred to 10 ml CAMHB to obtain a final inoculum density of 
approximately 5 x 105 CFU/ml. The density was confirmed regularly by taking 10 µl of the 
inoculum and diluting it in 10 ml 0.9% saline. From this dilution 100 µl was spread on a blood 
agar plate and an interval of 10-100 CFU was considered as an acceptable inoculum variation. 
Broth microdilution was performed with VetMIC GN-mo panels, manufactured by The National 
Veterinary Institute, Uppsala, Sweden.  Each VetMIC-plate consists of 12x8 wells with different 
antibiotic substances in serial twofold dilutions in each column (Appendix 1) with raising 
concentration of active substance in the direction H-A.  
 
Each well was filled with 50 µl of the inoculum. The wells were sealed with a transparent covering 
tape and the panels were incubated for 17 hours at 36°C. After 17 hours the bacterial growth in the 
wells was investigated and the lowest antibiotic concentration that totally inhibited visible growth 
of bacteria was noted as the minimum inhibitory concentration (MIC). 
 
Cut-off values 
Cut-off values are used in the interpretation of resistance in bacteria. If the MIC exceeds the cut-
off value the bacterial strain classifies as resistant, if not it classifies as sensitive. The cut-off values 
in this report are the epidemiological cut-off values (ECOFFs) published by EUCAST on their 
webpage (www.eucast.org), presented in Table 4 below. 
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In this report the word resistant is used for isolates 
with reduced susceptibility for an antibiotic 
substance. Important to note to avoid 
misunderstanding is that resistance in this context 
does not always suggest clinical resistance. ECOFFs 
are set to find all the isolates that may have a 
resistance mechanism. 
 
 
 
 
 
 
 
 
Questionnaire 
The owner was interviewed regarding the farm structure, pig husbandry and the routines for 
antibiotic treatment (Appendix 2). The questions were asked by authors to this article together with 
a Thai speaking veterinary student who translated the questions to Thai and the farmer’s answers 
to English. 
To make sure the questions were well understood and easy to answer the questionnaire was first 
piloted on another farm, not connected to the study.  
 
Statistical analysis 
Statistical analysis was conducted in SAS software 9.4 (SAS Institute Inc., Cary, NC). Descriptive 
statistics were computed to define farm characteristics. To investigate associations between 
management factors, such as use of antibiotics and veterinary services, with resistance against 
different types of antibiotics, univariable logistic regression and Fisher’s exact test were used.  The 
statistical significance level was defined as a two-tailed P-value ≤0.05. 
  
Table 4. Epidemiological cut-off values for 
the included antimicrobials 
(www.eucast.org) 
Antimicrobial agent ECOFFs 
Ampicillin >8 
Ciprofloxacin >0.06 
Nalidixic acid >16 
Gentamicin >2 
Streptomycin >16 
Tetracycline >8 
Florfenicol >16 
Colistin >2 
Sulfamethoxazole >64 
Trimethoprim >2 
Chloramphenicol >16 
Meropenem >0.12 
Cefotaxime >0.25 
Ceftazidime >0.5 
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RESULTS 
Farm management and veterinary service 
A-farms 
The A-farms were breeding farms (i.e. produce weaned pigs that are sold to fattening farms). Eight 
of 14 farms held 100-200 sows, four held 201-300 sows and two held 301-400 sows. The sows 
were obtained from the company. It was only possible to get information from one A-farm about 
the weaned pigs – that farm had 300 sows and produced 600-700 weaned pigs each month. The 
sows were vaccinated against foot-and-mouth disease (FMD), atrophic rhinitis (AR), classical 
swine fever (CSF) and Aujeszky’s disease (AD). Hygiene and cleaning routines were based on a 
continuous flow system. Feces were removed from the floors every day. The floors of the gestation 
sows were cleaned with water every second or third day and the floors of the nursing sows were 
disinfected with glutaraldehyde to prepare farrowing unit. Evaporation system was used as cooling 
system. The nursing sows had concrete slatted floor and were confined in farrowing crates. The 
gestation sows had solid concrete floor and were confined in gestation crates. 
B-farms 
The B-farms were breeding farms (i.e. produce weaned pigs that are sold to fattening farms). Three 
of the twelve B-farms held 100-200 sows and nine held 201-300 sows. Five farms produced 400-
600 weaned pigs each month from 201-300 sows, no information was obtained from the other 
seven farms. The sows were obtained from the company. All of the B-farms vaccinated their sows 
against FMD, CSF and AD. Hygiene and cleaning routines were based on a continuous flow 
system. Feces were removed from the floors every day. The gestation barns were cleaned twice a 
week with water, detergent and glutaraldehyde and the same protocol were used for the nursing 
pens after weaning, following 7 days where the pen was left empty before next sow. They used 
evaporation system to cool the air. The nursing sows had concrete slatted floor and were confined 
in farrowing crates. The gestation sows had solid concrete floor and were confined in gestation 
crates. 
Private owned farm 
This farm held approx. 400 sows which were bred on the farm and produced 800-1000 weaned 
pigs each month. The farm was a combined breeding and farrow-to-finish farm. They vaccinated 
the sows against FMD, CSF, Pseudorabies, Porcine Reproductive and Respiratory Syndrome 
(PRRS), Porcine Circovirus (PCV) and Porcine Parvovirus (PPV). Hygiene and cleaning routines 
were based on a continuous flow system. Feces were removed from the floors every day and they 
also cleaned with water every day. Once a week the floors were disinfected with glutaraldehyde. 
Water and disinfection were used after weaning and the pen was left empty for 7 days before next 
sow. For cooling, the private owned farm used conventional (open air) system with fans. The 
nursing sows had slatted floor and were confined in farrowing crates. The gestation sows had 
slatted floor at the back of their pens, but solid concrete at the front and were confined in gestation 
crates. 
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Location 
  
Figure 1. Overview of the locations of the farms. Red: A, orange: B, grey: private owned. 
 28 
 
Antibiotic usage 
Among the farms in this study, 
penicillin and streptomycin were 
the most commonly used antibiotic 
substances for injection. The two 
companies had their own separate 
regimes regarding the antibiotic 
use but they had the same regimes 
on all of their farms respectively. 
A-farms 
A-farms (14 farms) administered 
Kitamycin in feed for both nursing 
and gestation sows (Figure 3). 
Penicillin and streptomycin were 
administered as injection for 
preventive purpose after farrowing 
(Figure 2). They obtained 
antibiotics from the company and 
the veterinarian at the company 
decided when and how to give 
antibiotics. 
B-farms 
B-farms (12 farms) used penicillin, streptomycin and enrofloxacin for injection when sows were 
ill (Figure 2) and oxytetracycline in the daily feed for nursing sows (Figure 3), but no antibiotics 
in the feed for gestation sows. No answers were obtained from the B-farms whether they gave 
antibiotics to sows as preventive 
treatment after farrowing. The 
antibiotics were obtained from the 
company and the veterinarian at the 
company decided when and how to 
give antibiotics. 
Private owned farm 
The private owned farm used 
penicillin and streptomycin for 
injection as preventive treatment after 
farrowing and amoxicillin, 
oxytetracycline and cefotaxime for 
injection as treatment when sows were 
ill (Figure 2). In the daily feed for both 
nursing and gestation sows, they 
Figure 2. Number of farms administrating antibiotics as 
injection in preventive purpose and for treatment. The 
columns represent number of farms using a specific 
antibiotic. Penicillin and streptomycin were used at 27 farms, 
enrofloxacin was used at twelve farms and amoxicillin, 
oxytetracycline and cefotaxime were used at one farm. 
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Figure 3. Number of farms administrating antibiotics 
in the daily feed for nursing sows. Amoxicillin and 
colistin were given at one farm whereas kitasamycin 
and oxytetracycline were given at 14 and 12 farms 
respectively. 
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administered amoxicillin and colistin (Figure 3). This farm was owned by a veterinarian who also 
was responsible for the antibiotic regimes and treatments. 
 
Antibiotic resistance 
Escherichia coli was isolated from all 81 samples cultured (100%). Two of the 81 isolates (2.5%) 
were susceptible to all antibiotics and 77 (95.1%) of the samples were multidrug resistant (MDR) 
i.e. resistant to three or more antibiotic categories (Table 5). The antibiotic substances that the 
isolates most commonly were resistant to were tetracycline and ampicillin – 86.3% and 85.2% 
respectively (Table 7). 
Distributions of MICs for different antibiotics are presented in Table 7. 
Results of antibiotic susceptibility on each farm are described below and presented in Table 8.  
One of the isolates (M13) was resistant to meropenem (MIC >0.25) as well as to the other β-lactam 
antibiotics (ampicillin, ceftazidime and cefotaxime). The MICs of the tested antibiotics for this 
strain are shown in Table 6.  
 
 
 
  
Table 6. MIC of the tested antibiotics 
for Escherichia coli strain M13. The 
results show a high MIC (>0.25) of 
meropenem. 
Antibiotic 
substance MIC 
Ampicillin >128 
Ciprofloxacin 1 
Nalidixic acid 128 
Gentamicin 1 
Streptomycin 128 
Tetracycline 32 
Florfenicol 8 
Colistin 2 
Sulfamethoxazole >1024 
Trimethoprim >16 
Chloramphenicol 16 
Meropenem >0.25 
Cefotaxime >2 
Ceftazidime >4 
Table 5. Multidrug resistance (MDR) in Escherichia 
coli. The table shows the number of isolates and the 
proportion (%) of isolates resistant to none or 
several of the antibiotic categories tested. 
Number of 
antibiotic categories 
to which an isolate 
was resistant 
Number of 
isolates Percent 
0 2 2.5 
1  0 0 
2 2 2.5 
≥3 77 95.1 
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 Table 7. Resistance and distributions of minimum inhibitory concentrations (MICs) for the isolates tested (n=81).  White fields denote range of 
dilutions tested for each substance. MICs higher than the highest concentration tested are given as the concentration closest above the range. MICs 
equal to or lower than (≤) the lowest concentration tested, are given as the lowest tested concentration (underlined). The ECOFF for each substance 
is presented as a vertical line. 
Antimicrobial 
agent 
Resistance 
(%) 
Distributions (%) of MICs (mg/L) 
≤0.008 0.016 0.03 0.06 0.12 0.25 0.5 1 2 4 8 16 32 64 128 256 512 1024 >1024 
Ampicillin 85.2        4.9 8.6 1.2     2.5 82.7    
Ciprofloxacin 48.1   9.9 42 4.9 4.9 23.5 6.2 8.6           
Nalidixic acid 30.8         14.8 35.8 14.8 3.7 1.2 1.2 4.9 23.5    
Gentamicin 7.4      1.2 29.6 51.9 9.9 3.7  1.2  2.5      
Streptomycin 76.5          3.7 4.9 14.8 27.2 14.8 13.6 8.6 12.3   
Tetracycline 86.3        2.5 3.7 3.7 3.7 12.3 22.2 37 14.8     
Florfenicol 2.4          7.4 38.3 51.9 1.2 1.2      
Colistin 0       75.3 19.8 4.9           
Sulfamethoxazole 84           6.2 8.6 1.2      84.0 
Trimethoprim 70.4      6.2 18.5 4.9     70.4       
Chloramphenicol 58          9.9 21.0 11.1 45.7 12.3      
Cefotaxime 1.2   7.4 56.8 33.3 1.2    1.2          
Ceftazidime 3.7    1.2 1.2 66.7 27.2 2.5   1.2         
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A-farms 
Highest resistance rate seemed to be for sulfamethoxazole to which 39 of 42 isolates (92.9%) were 
resistant. The three isolates that were susceptible to sulfamethoxazole were also susceptible to the 
other folate pathway inhibitor, trimethoprim. The isolates had also generally high resistance rate 
to ampicillin; 35 of 42 isolates (83.3%) were resistant. To tetracycline 32 of 42 isolates (76.2%) 
were resistant. Streptomycin resistance appeared in 28 of 42 isolates (66.7%), whereas the other 
aminoglycoside gentamicin had a generally low MIC and all isolates were sensitive. Resistance to 
chloramphenicol was found in 23 of 42 (54.8%) isolates but only one isolate were also resistant to 
the other amphenicol, florfenicol. Of the 42 isolates 15 (35.7%) were resistant to at least one of 
the quinolones, ciprofloxacin and nalidixic acid. Meropenem resistance was found in one single 
isolate (isolate M13, presented in Table 6), this isolate was also resistant to the other betalactams 
(ampicillin, cefotaxime and ceftazidime). No resistance was found against colistin. 
B-farms 
All of the 36 isolates (100%) were resistant to tetracycline. Many isolates were also resistant 
against streptomycin; 31 of 36 isolates (86.1%). Five were resistant to gentamicin and all of them 
were resistant to streptomycin as well. A generally high resistance rate was also seen against 
ampicillin (31 of 36, 86.1%). Sulfamethoxazole and trimethoprim (folate pathway inhibitors) 
resistance appeared in 26 of 36 isolates (72.2%) respectively and 31 isolates (86.1%) in total. Of 
the isolates 23 (63.9%) were resistant to ciprofloxacin and 14 of them (38.9%) were also resistant 
to the other quinolone, nalidixic acid. Chloramphenicol resistance appeared in 21 of 36 isolates 
(58.3%) however no isolate was resistant to florfenicol. No isolate was resistant to cefotaxime. 
Ceftazidime resistance appeared in one single isolate (2.8%), which was also resistant to 
ampicillin. No isolate was resistant to colistin.  
Private owned farm 
All of the three isolates (100%) were resistant to ampicillin, streptomycin, sulfamethoxazole, 
trimethoprim and chloramphenicol. Two of these isolates (66.7%) were also tetracycline resistant 
and one of them (33.3%) was furthermore resistant to the quinolones, gentamicin and florfenicol. 
None of the isolates were resistant to neither colistin nor the cephalosporins. 
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Table 8. Number of resistant and susceptible isolates found on each farm. Three isolates from each farm were tested for 
susceptibility against the antibiotic substances below. R=resistant isolate, S=Susceptible isolate. Amp=Ampicillin, 
Cip=Ciprofloxacin, Nal=Nalidixic acid, Gen=Gentamicin, Str=Streptomycin, Tet=Tetracycline, Flo=Florfenicol, 
Col=Colistin, Sum=Sulfamethoxazole, Trim=Trimethoprim, Chl=Chloramphenicol, Cot=Cefotaxime, Caz=Ceftazidime. 
Farm ID Amp Cip Nal Gen Str Tet Flo Col Sum Trim Chl Cot Caz 
A 1 RRR RSS SSS SSS SSS RRR SSS SSS RRR RSS SSS SSS SSS 
A 2 SSS RSS SSS SSS RSS RSS SSS SSS RSS RSS RSS SSS SSS 
A 3 RRR SSS SSS SSS RRS RRR SSS SSS RRS RRS RRS SSS SSS 
A 4 RRS SSS SSS SSS RRS RRS SSS SSS RRR RRR RRS SSS SSS 
A 5 RRR RSS RSS SSS RSS RRR SSS SSS RRR RRR RRS RSS RSS 
A 6 RRR RRS RSS SSS RRS RRS SSS SSS RRR RRS RRR SSS SSS 
A 7 RRR RRR RRR SSS RRR RRS SSS SSS RRR RSS SSS SSS SSS 
A 8 RRR RRS RRS SSS RRR RRS SSS SSS RRR RSS RRS SSS SSS 
A 9 RRS SSS SSS SSS RSS RRS SSS SSS RRR RRS RRS SSS SSS 
A 10 RRS RSS RSS SSS RRR RRR SSS SSS RRR RRS RRS SSS SSS 
A 11 RRR SSS SSS SSS RRR RRS SSS SSS RRR RSS RSS SSS SSS 
A 12 RRR RSS RSS SSS RRR RRS RSS SSS RRR RRR RRR SSS SSS 
A 13 RRR RRS RSS SSS RRS RRR SSS SSS RRR RRR RSS SSS SSS 
A 14 RRS RSS SSS SSS RRS RRS SSS SSS RRR RRR RRS SSS RSS 
B 1 RRS RSS SSS RSS RRR RRR SSS SSS RRS RSS RRS SSS SSS 
B 2 RRR RSS RSS RRS RRR RRR SSS SSS RRR RRS RRS SSS SSS 
B 3 RRR RRS RSS SSS RSS RRR SSS SSS RSS RRS RRS SSS SSS 
B 4 RRR RRR RSS SSS RRR RRR SSS SSS RSS RSS SSS SSS SSS 
B 5 RRR RSS SSS SSS RRR RRR SSS SSS RRS RRR RRS SSS SSS 
B 6 RRR RRR RSS RSS RRR RRR SSS SSS RRS RRS RRS SSS SSS 
B 7 RRS RRS RRS SSS RRR RRR SSS SSS RRR RRS RRS SSS RSS 
B 8 RRR RRS RSS SSS RRR RRR SSS SSS RRR RRR RRS SSS SSS 
B 9 RRS RRR RRS SSS RRR RRR SSS SSS RRR RRR RRS SSS SSS 
B 10 RSS RRS RRS SSS RSS RRR SSS SSS RRS RSS RSS SSS SSS 
B 11 RRR RRS RRS RSS RRR RRR SSS SSS RRR RRR RRR SSS SSS 
B 12 RRR RSS RSS SSS RRS RRR SSS SSS RSS RRR RSS SSS SSS 
Private owned RRR RSS RSS RSS RRR RRS RSS SSS RRR RRR RRR SSS SSS 
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Relationships between category of farm and resistance patterns 
E. coli isolated from the B-category farms were significantly less often resistance to gentamicin 
compared with the other farm categories (Table 9). No significant relationships between farm 
category and resistance were found for ampicillin, ciprofloxacin, nalidixic acid, florfenicol, 
chloramphenicol, tetracycline or ceftazidime. 
 
  
Table 9. Correlation between farm category and Gentamicin (GEN) resistance. Fisher’s exact test is 
used since there are less than 5 observations in at least one of the boxes. P-value = 0.0061. 
 
Farm 
category 
GEN 
Susceptible Resistant 
A 8 4 
B 14 0 
Private 0 1 
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DISCUSSION 
Associations between antibiotic resistance, antibiotic usage and management 
factors 
It should be noted that this is only speculations from observing the obtained results, as the number 
of farms included in the study were too few and the variations in management and antibiotic usage 
were too small to obtain statistically significant data. Nevertheless it is interesting to discuss 
indications of differences between the contract farms and associations between resistance pattern, 
antibiotic usage and farm management.  
In general the resistance pattern is quite similar when comparing the contract farms. B-farms had 
oxytetracycline in their feed which possibly could explain the high resistance rate to tetracycline 
(100%) compared to the A-farms (76%).  B-farms used, unlike A-farms, enrofloxacin for injection. 
Enrofloxacin is a quinolone like ciprofloxacin and nalidixic acid. The resistance rate for 
quinolones in this study was higher in the B-farms (64%) than in the A-farms (36%) which 
suggests a possible selection of quinolone resistant bacteria due to the usage of enrofloxacin. 
Furthermore B-farms had a generally high resistance rate against the aminoglycosides (88% of the 
isolates) compared to A-farms (67% of the isolates). These differences might be due to 
management factors but since no statistical significance could be obtained from this data no real 
conclusions can be made about potential associations. 
Statistical analysis 
The results from these tests are difficult to interpret since the private owned farm is only one farm. 
However the results indicate that the B-farms were less probable to show resistance against 
gentamicin, compared to A and the private owned farm. 
ESBL and ESBLCARBA 
Some of the results for meropenem were found to be unreliable, the meropenem MICs were 
therefore withdrawn from the study. Nevertheless, one of the isolates (M13) was found to have a 
high MIC for the betalactam antibiotics including meropenem. Whether this reduced susceptibility 
is caused by a carbapenemase or not needs to be confirmed through PCR (polymerase chain 
reaction). In case of confirming an ESBLCARBA it would be interesting to note that none of the 
farms included in this study used carbapenems for their pigs.  
If the strain is found to produce carbapenemase, this study might be the first to report an 
ESBLCARBA-producing E. coli from pigs in Thailand. 
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Comparison with data from Sweden, Europe and North America 
Antimicrobial usage 
The prudent use of antimicrobials in Sweden is in contrast to the seemingly widespread use in 
Thailand. Despite major efforts, no gathered information on antibiotic usage or sales in Thailand 
has been found, which hinder comparison with Sweden, Europe or Canada. Nevertheless, the 
results of the questionnaires in this study indicate an extensive use of antimicrobials in pigs, for 
therapeutic purpose as well as preventive and growth promoting purpose. It is furthermore clear 
that all of the farms routinely administered antibiotic as injection for preventive purpose after 
farrowing. Reasons to this wide use could be inadequate information and education among 
livestock personnel and insufficient national regulation and monitoring. Furthermore, the climate 
in Thailand promotes bacterial and fungal diseases which might result in increased antimicrobial 
use.  
Antimicrobial susceptibility 
As mentioned in the literature study, there are some differences in methods and interpretation 
between the reports and studies from different countries/areas, although the differences in 
resistance levels are striking. Sweden has the lowest resistance frequency for all included 
antibiotics and the lowest frequency of MDR strains (Table 3). In contrast, both studies from 
Thailand show very high resistance for all antibiotics compared to the other parts of the world. 
The Thai studies have quite similar levels of resistance where comparison is possible, with the 
exception for gentamicin for which the study from 2008 shows a substantially higher resistance. 
Earlier reports that investigated a possible correlation between antimicrobial usage and AMR 
indicate that the antimicrobial use correlates with the resistance pattern nationally (Chantziaras et 
al., 2014). Since Swedish pig industry is prudent in its use of antimicrobials and also has a 
comparatively low resistance pattern, it is not farfetched to suspect that the extent of resistance in 
this study and Jiwakanon et al. (2008) is influenced by the extensive use of antibiotics in Thailand.  
Note that the countries chosen for comparison in this study are selected partly from their data 
accessibility and do not represent the rest of the world. Such comparison would have to include 
continents with data limitations and shortage in surveillance systems, e.g. Africa or Asia. Thailand 
should therefore not be seen as an exception in this matter. Their high levels of resistance possibly 
match the global situation to a larger extent than Sweden, Europe or Canada.
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CONCLUSIONS 
Even though there are undertakings regarding the AMR in Thailand, such as the ban of GPAs, the 
picture of antimicrobial use in animals remains less defined. In the European Union a surveillance 
program already exists (European Surveillance of Veterinary Antimicrobial Consumption, 
ESVAC) to identify risk factors for antimicrobial resistance. This surveillance also allows the 
comparison of antibiotic usage between countries. A similar program would be needed in Thailand 
as well as other Southeast Asian countries to be able to draw plausible conclusions regarding the 
effect of antibiotic usage in this region. 
This study shows a wide use of antibiotics in the farms included. Not to say the least for preventive 
purpose after farrowing, where all of the farms administered antibiotics as injection as a routine. 
The results from the antibiotic susceptibility tests display a generally high MIC, and a high 
resistance frequency, for a majority of the included antibiotics. These results indicate that a wide 
use of antibiotics results in resistant bacteria. Therefore, implementing a prudent antibiotic use, as 
well as surveillance systems, in Thailand, as well as globally is important to curb the development 
of more resistant bacteria. 
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APPENDICES 
Appendix 1 
Art.no: 395103 
VetMIC GN-mo (version 2015-07) 
Panel for monitoring of resistance in Gram-negative bacteria 
50 l/well gives concentrations as below 
 
GN-mo 
2015-07 
 
1 2 3 4 5 6 7 8 9 10 11 12 
A 
 
 
Am Ci Nal Gm Sm Tc Ff Su Tm Cm Ctx Caz 
128 1 128 32 256 128 32 1024 16 32 2 4 
B             
64 
 
0.5 64 
 
16 128 64 
 
16 512 8 16 1 2 
C             
32 0.25 32 8 64 32 8 256 4 8 0.5 1 
D             
16 0.12 16 4 32 16 4 128 2 4 0.25 0.5 
E       Cs   Mp   
8 0.06 8 2 16 8 4 64 1 0.25 0.12 0.25 
F             
4 0.03 4 1 8 4 2 32 0.5 0.12 0.06 0.12 
G             
2 0.016 2 0.5 4 2 1 16 0.25 0.06 0.03 0.06 
H           dist tri-cit 
1 0.008 1 0.25 2 1 0.5 8 0.12 0.03 cont cont 
 
Am  Ampicillin Cs Colistin 
Ci Ciprofloxacin Su  Sulfamethoxazole  
Nal  Nalidixic acid Tm  Trimethoprim 
Gm Gentamicin Cm  Chloramphenicol 
Sm Streptomycin Mp Meropenem 
Tc Tetracycline Ctx Cefotaxime 
Ff Florfenicol Caz Ceftazidime 
 
Note: No growth in the tri-cit control well implies that the strain is sensitive to the citric acid 
included in the buffer used for Am. In such case, reading of MIC for Am is not relevant 
Repeat testing with 100l per well to dilute the citric acid.  
Note! The concentration in the wells will be half of that noted above. Reading of MICs will  
have to be adjusted accordingly. 
 
Isolate 
 
Date 
 
Remarks 
 
Panel 
 
Mueller Hinton batch 
 
Signature 
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Appendix 2 
Questionnaire – medium-sized farms 
 
 
Name of the owner of the farm: 
 
 
GPS-coordinations:  
 
Working position of person answering the 
questionnaire: 
 
 
Type of farm (farrow-to-finish/breeding): 
 
Number of sows: 
 
Number of weaned pigs/month: 
1. From where do you get your sows? 
a. Breed our own 
b. From the company 
c. From another farm in the district 
d. From another farm, not in the same district 
e. Other: 
Questions about antibiotic usage 
2. Do you give antibiotics in the feed? 
Yes/No 
3. Which sows do you give antibiotics in the feed? 
a. Nursing sows 
b. Gestation sows 
c. Nursing and gestation 
4. What kind of antibiotics do you use? 
a. In the daily feed for nursing sows: 
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b. In the daily feed for gestation sows: 
 
 
 
 
 
c. For injections in sows that are ill (including treatment protocol): 
Type of antibiotic                                                                      Number of days in treatment 
 
 
 
 
d. By feed to sows that are ill (including treatment protocol): 
Type of antibiotic                                                                     Number of days in treatment 
 
 
 
5. At how many occasions (on avarage) per year is a sow treated (p.o. respectively i.m.) 
Per os : 
Intramuscular :  
6. How do you get access to the antibiotics? 
a. From the company 
b. Buy from veterinarian 
c. Buy from local store/pharmacy 
d. Other: 
 
 
 
 
 
7. How much feed do the sows get per day and how much antibiotics does the feed contain? 
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  How often? How much? 
Antibiotic 
concentration? 
Nursing 
  Times/d  Kg/d 300-400 ppm  
Gestation       
 Times/d Kg/d  
 
8. Who decides about when and how to give antibiotics if a sow gets ill?  
a. Veterinarian 
b. Small doctor 
c. Foreman 
d. Worker 
e. Other person:  
9. Do you vaccinate the pigs? Against which diseases? 
Yes/No 
 
Questions regarding husbandry 
10. Do you use a “continuous flow system” or an “all-in, all-out system” in the farrowing units? 
 
 
11. How often are the floors  
a. cleaned from faeces with a broom (or something similar)? 
b. washed with water/soap/disinfection? 
a.  
 
b.  
 
12. What type of disinfection do you use for cleaning? 
 
 
 
 
For us to fill in 
13. Type of cooling system? (Evaporation/conventional (open air) system) 
a. Evaporation 
 v 
 
b. Conventional (open air) 
c. Other:  
 
14. What type of floor do the sows have? 
 
 
 
15. Are the sows confined? What type of confinement is used? 
 
 
 
16. Density of farms in the village? (For us, look at the map) 
 
 
 
 
 
 
